SPR Therapeutics

SPRINT PNS System

Real-World Evidence of Significant and Sustained Outcomes Following 60-Day Peripheral Nerve Stimulation Treatment for Chronic Pain

Real-world evidence (RWE), derived from analysis of data from the routine use of a treatment or therapy in general clinical practice, has an important role in providing insight into treatment …
Read moreReal-World Evidence of Significant and Sustained Outcomes Following 60-Day Peripheral Nerve Stimulation Treatment for Chronic Pain
Category: Tag: , , , ,

How May Temporary 60-Day PNS Treatment Improve Identification of Delayed Responders and Non-Responders to Neurostimulation?

Peripheral nerve stimulation (PNS) has broad applications for pain relief and has been successfully used to treat myriad types of pain. Current conventional neurostimulation systems for pain relief …
Read moreHow May Temporary 60-Day PNS Treatment Improve Identification of Delayed Responders and Non-Responders to Neurostimulation?
Category: Tag: , , ,

FDA Clearance of an Expanded Indication for the SPRINT® PNS System Now Enables Treatment in Areas of the Head, Neck, and Torso

–Data from 5,518 Patients were Critical to Achieving the Broader Indication– Cleveland, Ohio- October 19, 2021- SPR Therapeutics® has obtained clearance from the U.S. Food and Drug Administration …
Read moreFDA Clearance of an Expanded Indication for the SPRINT® PNS System Now Enables Treatment in Areas of the Head, Neck, and Torso
Category: Tag: , , , , , ,

SPR Therapeutics Closes $37 Million Growth Equity Financing for Commercial Expansion of its SPRINT® PNS System

– Expanding U.S. Commercial Team Amid Record-Breaking Growth – Cleveland, Ohio- October 18, 2021- SPR Therapeutics, a private medical device company focused on providing patients with pain relief …
Read moreSPR Therapeutics Closes $37 Million Growth Equity Financing for Commercial Expansion of its SPRINT® PNS System
Category: Tag: , , , , ,